Recent Posts
- One-year usage patterns of SGLT-2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes in a real-world population
- SGLT2 Inhibitor and GLP-1 Receptor Agonist Prescriptions in Newly Diagnosed Type 2 Diabetes Patients With Cardiorenal Risks: A Cross-Sectional Study
- Global Muslim Weight Management Group Ltd Announced as Sponsor of the British Muslim Health Awards 2025
- Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity
- Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists
CME/CPD Provider Number: CPDSO 50212
